Hjem › Schizofreni › Missouri
Kliniske studier for Schizofreni i Missouri
11 studier for Schizofreni søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- Washington University, St Louis
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 59 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07853807Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Midwest Research Group 1, Saint Charles
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, St Louis
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07114874A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0142, Columbia
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Arch Clinical Trials, St Louis
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT0741050752-week Open Label Safety-Tolerability Study
- Arch Clinical Trials, St Louis
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07369154Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Saint Charles
RekruttererFase 3
Alder 10 til 17 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Arch Clinical Trials LLC, St Louis
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Arch Clinical Trials, St Louis
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Arch Clinical Trials, St Louis
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07191483Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Saint Charles
- Vanda Investigational Site, St Louis
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06961968Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.